Table 1 Demographic characteristics of patients with adverse drug events (ADEs) leading to Emergency Departments (ED) visits
| Â | ADE-related ED visits | Serious ADE-related ED visits | Not serious ADE-related ED visits | |||
|---|---|---|---|---|---|---|
No. of Cases (%) | 95% CI | No. of Cases (%) | 95% CI | No. of Cases (%) | 95% CI | |
Gender | ||||||
aMales | 212 (36.9) | 32.9–40.8 | 59 (34.7) | 27.5–41.9 | 149 (37.2) | 32.4–41.9 |
Females | 363 (63.1) | 59.2–67.1 | 111 (65.3) | 58.1–72.5 | 252 (62.8) | 58.1–67.6 |
Patient age group, years | ||||||
b18–34 | 118 (20.5) | 17.2–23.8 | 27 (15.6) | 10.2–21.0 | 86 (22.2) | 18.1–26.3 |
c35-49 | 143 (24.1) | 20.6–27.5 | 23 (13.3) | 8.2–18.4 | 118 (28.3) | 24.0–32.6 |
50–64 | 150 (25.3) | 21.8–28.7 | 39 (22.5) | 16.3–28.8 | 111 (26.6) | 22.4–30.9 |
65–79 | 116 (19.5) | 16.3–22.7 | 52 (30.1) | 23.2–36.9 | 64 (15.3) | 11.9–18.8 |
≥80 | 48 (8.1) | 5.9–10.3 | 29 (16.8) | 11.2–22.3 | 19 (4.6) | 2.6–6.6 |
No. of medications by category | ||||||
d1 | 380 (66.1) | 62.2–70.0 | 57 (33.5) | 26.4–40.6 | 319 (79.6) | 75.6–83.5 |
≥2 | 195 (33.9) | 30.0–37.8 | 113 (66.5) | 59.4–73.6 | 85 (20.4) | 16.5–24.4 |
Preventability assessment | ||||||
Certainly preventable | 71 (12.3) | 9.7–15.0 | 42 (24.7) | 18.2–31.2 | 29 (7.2) | 4.7–9.8 |
Probably preventablee | 336 (58.4) | 54.4–62.5 | 101 (59.4) | 52.0–66.8 | 232 (57.9) | 53.0–62.7 |
Not-preventablef | 168 (29.2) | 25.5–32.9 | 27 (15.9) | 10.4–21.4 | 140 (34.9) | 30.2–39.6 |